Theriva Biologics Statistics
Total Valuation
TOVX has a market cap or net worth of $4.53 million. The enterprise value is -$11.82 million.
| Market Cap | 4.53M |
| Enterprise Value | -11.82M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TOVX has 17.28 million shares outstanding. The number of shares has increased by 13.38% in one year.
| Shares Outstanding | 17.28M |
| Shares Change (YoY) | +13.38% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 1.92% |
| Owned by Institutions (%) | 4.58% |
| Float | 16.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.60 |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.30% and return on invested capital (ROIC) is -64.80%.
| Return on Equity (ROE) | -49.30% |
| Return on Assets (ROA) | -33.00% |
| Return on Capital (ROIC) | -64.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$865,318 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.84% in the last 52 weeks. The beta is 1.38, so TOVX's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -62.84% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.42 |
| Relative Strength Index (RSI) | 48.10 |
| Average Volume (20 Days) | 138,882 |
Short Selling Information
The latest short interest is 457,802, so 2.65% of the outstanding shares have been sold short.
| Short Interest | 457,802 |
| Short Previous Month | 683,184 |
| Short % of Shares Out | 2.65% |
| Short % of Float | 2.70% |
| Short Ratio (days to cover) | 1.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.65M |
| Pretax Income | -20.35M |
| Net Income | -19.04M |
| EBITDA | -19.71M |
| EBIT | -20.35M |
| Earnings Per Share (EPS) | -$1.16 |
Balance Sheet
The company has $18.36 million in cash and $2.02 million in debt, giving a net cash position of $16.34 million or $0.95 per share.
| Cash & Cash Equivalents | 18.36M |
| Total Debt | 2.02M |
| Net Cash | 16.34M |
| Net Cash Per Share | $0.95 |
| Equity (Book Value) | 31.39M |
| Book Value Per Share | 1.82 |
| Working Capital | 15.65M |
Cash Flow
In the last 12 months, operating cash flow was -$18.27 million and capital expenditures -$194,000, giving a free cash flow of -$18.46 million.
| Operating Cash Flow | -18.27M |
| Capital Expenditures | -194,000 |
| Free Cash Flow | -18.46M |
| FCF Per Share | -$1.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TOVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.38% |
| Shareholder Yield | -13.38% |
| Earnings Yield | -420.55% |
| FCF Yield | -407.83% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 25, 2022. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |